BioNJ ( BioNJ)

Primary tabs

BioNJ's picture

Management

Contact Address

About BioNJ

BioNJ has been hard at work in its mission to enhance the climate for biotechnology in the state. As the representative of an industry that has the potential to change the course of human health, make our environment cleaner and the foods we eat safer and healthier, BioNJ is single-minded in its commitment to the growth and prosperity of this industry within the state of New Jersey. It has been an exciting time for the biotechnology industry and for BioNJ, and it is with pride and commitment to the future that we highlight some of the important developments in the public policy, education, networking, and member services that are helping to foster the growth and prosperity of this important industry

BioNJ press release, blog etc

Fri, 05/23/2025 - 13:57 Master Protocols in Clinical Trials: Driving Innovation, Efficiency & Patient-Centric Research
Thu, 07/11/2024 - 03:03 BioNJ Announces Strategic Collaboration with Tech Council Ventures to Boost Life Sciences Innovation
Fri, 07/02/2021 - 07:50 Eiger BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Tue, 06/08/2021 - 08:20 AI in Drug Discovery Briefing
Thu, 01/14/2021 - 12:10 China and U.S. Collaboration: Innovation on the Horizon
Fri, 07/31/2020 - 19:21 Ginkgo Bioworks Awarded $40MM NIH RADx-ATP Contract to Expand High Throughput SARS-CoV-2 Testing
Fri, 07/31/2020 - 19:18 FDA In Brief: FDA Advises Consumers to Avoid Red Onions from California Supplier, Investigation Continues to Find Source
Fri, 07/31/2020 - 18:57 Coronavirus (COVID-19) Update: FDA Authorizes First Two Tests that Estimate a Patient's Antibodies from Past SARS-CoV-2 Infection
Fri, 07/31/2020 - 17:51 AGC to Complete the Acquisition of MolMed on July 31, 2020
Wed, 07/29/2020 - 19:34 Evogene to Present at Jefferies Virtual 2020 Industrials Conference
Wed, 07/29/2020 - 18:29 Immunic, Inc. to Participate in Investor Conferences in August
Wed, 07/29/2020 - 17:17 INOVIO Receives Orphan Drug Designation From U.S. FDA for DNA Medicine INO-3107 To Treat Rare Disease Recurrent Respiratory Papillomatosis (RRP)
Tue, 07/28/2020 - 17:40 New Corona Test Kit: Two antibody tests from one drop of blood thanks to innovative DBS technology
Mon, 07/27/2020 - 19:21 Scripta Insights Co-founder & Chief Medical Officer Paul S. Bradley, MD, at Forefront of Medical Advancement, Doses First Patient in Moderna's U.S. Phase 3 COVID-19 Vaccine Clinical Trial
Wed, 07/22/2020 - 17:36 CASI Pharmaceuticals Announces Pricing Of $38,000,000 Public Offering Of Common Stock
Wed, 07/15/2020 - 19:09 Terumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field
Tue, 07/14/2020 - 17:29 Bridge Biotherapeutics becomes BaseLaunch's first Asia Pacific partner
Wed, 06/17/2020 - 19:11 Truvian Sciences Expands Focus to Address Surge in Demand for Antibody Tests; Introduces Easy Check COVID-19 IgM/IgG Test